Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Phase 1B Study for Assessment of Safety and Therapeutic Efficacy of Promitil in Combination With Oxaliplatin-based Chemotherapy in Patients With Gastro-intestinal Malignancies

NCT04729205 is registered in ClinicalTrials.gov with Lipomedix Pharmaceuticals Inc. as lead sponsor.

NCT NCT04729205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04729205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Phase 1B Study for Assessment of Safety and Therapeutic Efficacy of Promitil in Combination With Oxaliplatin-based Chemotherapy in Patients With Gastro-intestinal Malignancies
Lead sponsor
Lipomedix Pharmaceuticals Inc.
Phase
Phase 1
Overall status
Terminated
Start date
January 13, 2021
Completion date
September 12, 2023
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, gastro-intestinal intraepithelial neoplasia